secwatch.observer — SEC 8-K summary
======================================

Issuer:     Minerva Neurosciences, Inc. (NERV)
CIK:        0001598646
Form:       8-K
Filed at:   2023-06-28T23:59:59+00:00
Accession:  0001193125-23-176877
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Minerva Neurosciences raises $20M in PIPE at $10/share for roluperidone launch
------------------------------------------------------------------------------

- Gross proceeds ~$20M from 1,425,000 shares at $10/share and 575,575 pre-funded warrants at $9.99.
- Investors include Boehringer Ingelheim and Federated Hermes Kaufmann Funds; Boehringer gets board observer rights.
- Net proceeds to support U.S. regulatory approval, commercialization, and launch of roluperidone for negative schizophrenia symptoms.
- Closing expected on or about June 30, 2023, subject to customary closing conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1598646/000119312523176877/0001193125-23-176877-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1598646/000119312523176877/d527050d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-176877

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer